{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-21-007914","form_type":"8-K","ticker":"ANIK","cik":"0000898437","company_name":"Anika Therapeutics, Inc.","filed_at":"2021-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.140337+00:00","generated_at":"2026-06-28T08:51:11.969158+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Anika Therapeutics enters $75M senior revolving credit facility maturing 2026","bullets":["Third Amendment to Credit Agreement increases revolving line to $75M, expandable to $150M.","Maturity date extended to November 12, 2026; interest at BSBY + 0.25%-1.00%.","Amended agreement governs leverage and interest coverage covenants; first-priority lien on assets.","Bank of America serves as administrative agent; new lenders join the facility."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-21-007914","json":"https://secwatch.observer/filing/0001171843-21-007914.json","markdown":"https://secwatch.observer/filing/0001171843-21-007914.md","text":"https://secwatch.observer/filing/0001171843-21-007914.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/898437/000117184321007914/0001171843-21-007914-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/898437/000117184321007914/f8k_111521.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T08:51:11.969158+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}